Noble Biomaterials, Inc.
PrivateLast Round
Debt
Aug 18, 2022
Total Funding Raised
$8.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Noble Biomaterials, Inc. is a materials science company that develops, manufactures, and markets antimicrobial and conductive technologies for applications in the performance apparel, healthcare, industrial, and military markets.
Sector
Frontier & Industrial Tech
Verticals
Advanced Materials, Medical Devices, Sensors, Sports & Fitness, Defense Tech
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Noble Biomaterials, Inc. Comparables
Compare Noble Biomaterials, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sciessent | 86% | |
| PurThread Technologies | 81% | |
| Heiq PLC | 80% |
Noble Biomaterials, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 18, 2022 | ||||
| Debt | Oct 18, 2021 | ||||
| Series B | Feb 10, 2012 |
Key People
Founding team and executive leadership
Noble Biomaterials, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northwater Capital Management | Series B |
| Benjamin Franklin Technology Partners | Debt |
| TL Ventures | Series B |
| DuPont Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 54% MoM, reaching 2.3K.
- Jan 20, 2026
Attending the 2026 PGA Show to showcase material technologies.
Noble Biomaterials, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Noble Biomaterials, Inc.'s valuation, stock price, and market status.
Is Noble Biomaterials, Inc. a public or private company?
Noble Biomaterials, Inc. is a private company.
What is the current stock price of Noble Biomaterials, Inc.?
Noble Biomaterials, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Noble Biomaterials, Inc. worth (valuation)?
Valuation information for Noble Biomaterials, Inc. is not publicly available.
Can I buy Noble Biomaterials, Inc. stock?
Noble Biomaterials, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Noble Biomaterials, Inc.'s last funding round?
Noble Biomaterials, Inc.'s most recent funding round was Debt on August 18, 2022.
Who are the main investors in Noble Biomaterials, Inc.?
Key investors in Noble Biomaterials, Inc. include Northwater Capital Management.
Will Noble Biomaterials, Inc. IPO soon?
No public IPO plans have been announced for Noble Biomaterials, Inc..
How can I track Noble Biomaterials, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Noble Biomaterials, Inc.'s secondary market activity and sign up for updates.